| ²é¿´: 1741 | »Ø¸´: 28 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
york6999ľ³æÖ®Íõ (ÖªÃû×÷¼Ò)
|
[½»Á÷]
Privileged Scaffolds in Medicinal Chemistry
|
||
|
Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation by Stefan Bräse and David Thurston RCS 2015 |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Privileged_scaffold.rar
2016-05-07 22:07:56, 7.2 M
» ²ÂÄãϲ»¶
085600 295·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
»·¾³¹¤³Ì297·ÖÇóµ÷¼ÁÒ»Ö¾Ô¸º¼¸ßÔº
ÒѾÓÐ3È˻ظ´
Àíѧ07»¯Ñ§ 303Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
290·Öµ÷¼ÁÇóÖú
ÒѾÓÐ6È˻ظ´
362Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304
ÒѾÓÐ17È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ÕÅ·¼Ãú-Öйúũҵ´óѧ-»·¾³¹¤³Ìר˶-298
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§354Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ò©Î↑·¢ÖذõÊé¼®£¡Privileged Scaffolds in Medicinal Chemistry
ÒѾÓÐ215È˻ظ´
ÇóPrivileged Scaffolds in Medicinal ChemistryÒ»±¾
ÒѾÓÐ1È˻ظ´
ÇóÖúPrivileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation
ÒѾÓÐ2È˻ظ´
Privileged Scaffolds in Medicinal Chemistry : Design, Synthesis, Evaluation
ÒѾÓÐ1È˻ظ´
ÇóÊé¼®
ÒѾÓÐ3È˻ظ´
|
¶¥Ò»Ï£¬Ð»Ð»·ÖÏí ·¢×ÔСľ³æAndroid¿Í»§¶Ë |
9Â¥2016-05-09 06:11:25
0.8
| ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡ |
2Â¥2016-05-07 22:16:39
0.6
| ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡ |
3Â¥2016-05-08 09:05:26
0.8
| ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡ |
4Â¥2016-05-08 09:39:53














»Ø¸´´ËÂ¥